1. Home
  2. IBCP vs IOVA Comparison

IBCP vs IOVA Comparison

Compare IBCP & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Independent Bank Corporation

IBCP

Independent Bank Corporation

HOLD

Current Price

$32.55

Market Cap

674.7M

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.73

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBCP
IOVA
Founded
1864
2007
Country
United States
United States
Employees
270
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
674.7M
1.6B
IPO Year
2010
2008

Fundamental Metrics

Financial Performance
Metric
IBCP
IOVA
Price
$32.55
$3.73
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$36.67
$9.11
AVG Volume (30 Days)
144.4K
18.3M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.41%
N/A
EPS Growth
3.48
14.84
EPS
3.27
N/A
Revenue
$32,075,000.00
N/A
Revenue This Year
N/A
$51.55
Revenue Next Year
$5.46
$37.55
P/E Ratio
$10.05
N/A
Revenue Growth
0.30
N/A
52 Week Low
$26.75
$1.64
52 Week High
$37.39
$5.63

Technical Indicators

Market Signals
Indicator
IBCP
IOVA
Relative Strength Index (RSI) 38.05 49.05
Support Level $30.09 $2.02
Resistance Level $33.47 $4.34
Average True Range (ATR) 0.98 0.41
MACD -0.09 -0.14
Stochastic Oscillator 32.91 12.95

Price Performance

Historical Comparison
IBCP
IOVA

About IBCP Independent Bank Corporation

Independent Bank Corp. operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers. The firm's principal markets are the rural and suburban communities across Lower Michigan. The firm generates the majority of its revenue from Interest and fees on loans.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: